Universal Cells
Arni Gagnidze has extensive experience in research and development, specializing in gene editing and stem cell technology. They have worked in various roles at Universal Cells, Etubics, and the University of Washington School of Medicine, focusing on viral vector gene delivery systems and immunotherapies for cancer treatment. Arni holds a Bachelor's Degree from Washington State University.
Universal Cells
Universal Cells is a Seattle-based biotech developing, licensing and commercializing stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using the company's proprietary genome editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyteantigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient.